Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Financial Toxicity clinical trials
5 of 6 indexed Financial Toxicity trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Financial Toxicity: 6 US clinical trials tracked, 5 recruiting.
Financial Toxicity is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is Barbara Ann Karmanos Cancer Institute, running 2 of these trials.
Enrollment posture brief
Registry condition financial-toxicity
OPEN 5 | RECR 83% | LATE 0 | EARLY 0 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)
Financial Toxicity lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Financial Toxicity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Financial Toxicity is recruiting above its size-band peers.
5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Financial Toxicity research.
Barbara Ann Karmanos Cancer Institute accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Financial Toxicity trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.
-
Financial Toxicity research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
Lauren Hamel
NCT04766190
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
M.D. Anderson Cancer Center
NCT07215611
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
University of Alabama at Birmingham
NCT07281287
Proactive Costs of Care Study
Cedars-Sinai Medical Center
NCT07217262
A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
Barbara Ann Karmanos Cancer Institute
NCT07042191
Feasibility and Utilization of an Application-based Question Prompt List
Barbara Ann Karmanos Cancer Institute
NCT03676920
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Financial Toxicity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Financial Toxicity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Financial Toxicity page
6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Financial Toxicity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Barbara Ann Karmanos Cancer Institute sponsors the most Financial Toxicity trials on record, review their full trial history before evaluating a specific study. See Barbara Ann Karmanos Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Financial Toxicity condition card totals 6 registered trials; most-linked intervention Discussions of Cost App (DISCO App); top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.